PillRx only · Injection · Intramuscular
Furosemide
Furosemide
6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US17 NDCs
6 active makers
6 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.365
Latest avg · Jul 22, 2026
+63%
Since Jul 23, 2025
6
Active US suppliers
47%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
697
Rx · 2026 Q1
3.6K
Units dispensed
-9%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it6 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc. | unknown | 5 | SUPPLYING |
| Accord Healthcare Inc. | unknown | 3 | SUPPLYING |
| Micro Labs Limited | unknown | 3 | SUPPLYING |
| Amneal Pharmaceuticals LLC | unknown | 3 | SUPPLYING |
| Medical Purchasing Solutions, LLC | unknown | 2 | SUPPLYING |
| Civica, Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Apr 7, 2020SHORTAGEDrug shortage: Furosemide Injection (Accord Healthcare Inc.)
Furosemide Injection — reported in shortage by Accord Healthcare Inc.. Therapeutic category: Cardiovascular.